Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 18Unknown 12Recruiting 10Not yet recruiting 4Terminated 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Breast 1

Conditions

Breast Neoplasms 430Neoplasms 284Carcinoma, Non-Small-Cell Lung 266Colorectal Neoplasms 228Lung Neoplasms 173Prostatic Neoplasms 171Carcinoma, Hepatocellular 156Stomach Neoplasms 129Leukemia, Myeloid, Acute 118Pancreatic Neoplasms 115Multiple Myeloma 105Recurrence 96Uterine Cervical Neoplasms 91Squamous Cell Carcinoma of Head and Neck 88Neoplasm Metastasis 87Rectal Neoplasms 85Ovarian Neoplasms 77Triple Negative Breast Neoplasms 75Small Cell Lung Carcinoma 72Head and Neck Neoplasms 68Brain Neoplasms 68Esophageal Neoplasms 64Glioblastoma 63Colonic Neoplasms 60Endometrial Neoplasms 58Melanoma 54Hematologic Neoplasms 53Motor Activity 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Nasopharyngeal Carcinoma 46

Interventions

Radiosurgery 1Panitumumab 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Neoplasms, Second Primary × Clear all
NCT05832138 2025-10-06

ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in Ontario

The Hospital for Sick Children

Phase NA Not yet recruiting
900 enrolled
BreastGastrointestinal

Breast Neoplasms, Heart Diseases, Neoplasms, Colorectal Neoplasms, Neoplasms, Second Primary

NCT05578274 2024-12-10

Abscopal Effect from Low-dose Radiotherapy in Metastatic Cancer Combined with Stereotactic Body Radiotherapy

Soonchunhyang University Hospital

Phase NA Not yet recruiting
186 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms, Neoplasms, Second Primary

NCT06523322 2024-07-26

Culinary Medicine for Cancer Caregivers

Drexel University

Phase NA Not yet recruiting
20 enrolled

Caregiver Burden, Neoplasms, Neoplasms, Second Primary

NCT04034173 2019-07-26

Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation

Ludwig-Maximilians - University of Munich

Phase 2 Not yet recruiting
120 enrolled
Gastrointestinal

Colorectal Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡